Education and debate

Malignant tumours in patients with HIV infection

BMJ 1994; 308 doi: 10.1136/bmj.308.6937.1148 (Published 30 April 1994)
Cite this as: BMJ 1994;308:1148

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Umberto Tirellia,
  2. Silvia Franceschia,
  3. Antonino Carbonea
  1. division of medical oncology and AIDS
  2. epidemiology unit
  3. a Centro Regionale di Riferimento Oncologico, Istituto Nazionale di Ricovero e Cura a Carattere Scientifico, 33081 Aviano, Italy
  4. division of pathology Series editor: G M Mead (G M Mead is consultant in medical oncology at the Cancer Research Campaign's Wessex Medical Oncology Unit)
  1. Correspondence to: Dr Tirelli.

    One of the most important though somewhat neglected aspects of research in HIV infection concerns the development, clinicopathological characteristics, and treatment of malignant tumours in infected patients. With the improved survival of patients with AIDS owing to the better prevention and treatment of infectious complications there may well be an increase in AIDS related malignancies. This paper reviews the epidemiology, pathology, and treatment of malignant tumours in patients with HIV.

    This is the seventh in a series of articles examining developments in cancer and updating what we know about the disease

    What are the main types of cancer in AIDS?

    At least two malignancies are firmly established as associated with HIV and have long been diagnostic of AIDS--namely, Kaposi's sarcoma and non-Hodgkin's lymphoma (table). When compared with the general population in the same area, the risk of Kaposi's sarcoma in men with AIDS was roughly 900-fold greater in the State of Illinois1 and 700-fold greater in San Francisco Bay.2 Data from the same cancer registry linkage studies for non-Hodgkin's lymphoma showed standardised incidence ratios of 1411 and 712 respectively (table). More detailed analyses by subtype of non-Hodgkin's lymphoma suggested that the standardised incidence ratio in single men aged 20-49 in 1985-7 as compared with 1973-8 was 43 for the extranodal form but only 8 for nodal disease.3 With respect to histological grade, the increased standardised incidence ratio was restricted to intermediate and high grade lymphomas.3

    View this table:
    • In this window
    • In a new window

    Risk of cancer in men with AIDS or at risk of AIDS

    In the largest cancer registry linkage study2 solid tumours as a whole did not occur more often than expected among patients with AIDS, but two types of cancer which are not part of the AIDS case definition occurred with significantly increased frequency. These were Hodgkin's disease (standardised incidence ratio 8.8) and cancers of the rectum, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular